Wolff Wiese Magana LLC Cuts Stock Holdings in Kenvue Inc. $KVUE

Wolff Wiese Magana LLC reduced its stake in Kenvue Inc. (NYSE:KVUE) by 94.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 4,205 shares of the company’s stock after selling 75,052 shares during the quarter. Wolff Wiese Magana LLC’s holdings in Kenvue were worth $73,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of KVUE. Norges Bank bought a new stake in shares of Kenvue in the 2nd quarter worth $537,418,000. Independent Franchise Partners LLP grew its position in Kenvue by 233.4% in the 2nd quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock worth $654,388,000 after purchasing an additional 21,886,537 shares in the last quarter. Van ECK Associates Corp grew its position in Kenvue by 101.3% in the 3rd quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock worth $298,008,000 after purchasing an additional 9,240,434 shares in the last quarter. American Century Companies Inc. increased its stake in Kenvue by 22.4% in the 3rd quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock valued at $601,267,000 after buying an additional 6,781,640 shares during the last quarter. Finally, Amundi lifted its position in shares of Kenvue by 82.5% during the 2nd quarter. Amundi now owns 14,509,890 shares of the company’s stock worth $305,446,000 after buying an additional 6,559,261 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Kenvue Trading Down 0.3%

Shares of KVUE opened at $17.52 on Friday. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The business has a 50-day moving average of $18.01 and a 200 day moving average of $17.14. The firm has a market cap of $33.57 billion, a P/E ratio of 22.75, a price-to-earnings-growth ratio of 3.99 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96.

Kenvue (NYSE:KVUE) last issued its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The firm had revenue of $3.78 billion during the quarter, compared to analyst estimates of $3.68 billion. During the same quarter last year, the business earned $0.26 earnings per share. The company’s quarterly revenue was up 3.2% on a year-over-year basis. As a group, research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were issued a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. Kenvue’s payout ratio is presently 107.79%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on KVUE. Barclays boosted their target price on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Friday, March 6th. Canaccord Genuity Group boosted their price objective on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Wednesday, February 18th. Jefferies Financial Group downgraded Kenvue from a “buy” rating to a “hold” rating and reduced their price objective for the company from $23.00 to $18.00 in a research note on Friday, January 30th. Argus upgraded Kenvue to a “hold” rating in a research note on Friday, March 6th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Three investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $19.58.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.